CD8A and neoplasm: In multiple tumor xenograft models, nanometric NanoAlb‐proDOX showed superior antitumor activity and synergy with immune checkpoint blockade, probably due to the synergistically enhanced tumor CD8+ T‐cell infiltration and activation.